Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine

被引：0
|
作者：
Clarke, G. [1 ,2 ]
Naughton, M. [1 ]
O'Shea, R. [3 ]
Dowling, J. [4 ]
Walsh, A. [4 ]
Ismail, F. [1 ]
Shorten, G. [4 ]
Scott, L. [1 ]
Cryan, J. F. [2 ,5 ]
Dinan, T. G. [1 ,2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Sch Med, Cork, Ireland
[4] Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland
[5] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70736-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.015
引用
收藏
页码：S460 / S460
页数：1
相关论文
共 50 条
  • [1] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S
  • [2] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Nolan, Neal M.
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : E417 - E423
  • [3] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [4] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [5] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [6] Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression
    Kang, M.
    Hawken, E.
    Bahji, A.
    Brietzke, E.
    Vazquez, G.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S113 - S113
  • [7] Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
    Liu, Linda Xing Yu
    Golts, Marina
    Fernandes, Virginia
    [J]. PHARMACY, 2021, 9 (03)
  • [8] Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?
    Rush, A. John
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10): : 1079 - 1081
  • [9] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: READY FOR CLINICAL TRANSLATION?
    Loo, C. K.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 10 - 10
  • [10] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
12345